Back to Agenda
How Common Data Models Can Address the Challenges in the Use of Clinical Trial and Real-World Data for Evidence Generation
Session Chair(s)
Jesper Kjær, MS
Global Director for Public, Private Partnerships, Strat Ops, Global Med Affairs
Novo Nordisk, Denmark
This panel will discuss different types of data models that exist and their strengths and weaknesses in relation to real-world data (RWD) and interoperability.
Learning Objective : Recognize the different types of data models that exist and their strengths and weaknesses in relation to real-world data (RWD) and interoperability; Discuss the appropriate data models for primary and secondary data and how clinical data managers can potentially help RWD and trial data to meet the evidentiary requirements for regulatory decision-making.
Speaker(s)
Panelist
Davera Gabriel, RN
Evidentli USA LLC, United States
Director of Client Success
Panelist
Jonathan Chainey
Roche, United States
Executive Director, Global Head, Data Standards and Governance, Data Sciences
Panelist
Stacy Tegan
Transcelerate Biopharma, Inc., United States
Program Director
Have an account?